MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effects of Expiratory Muscle Strength Training and Voice Therapy on Parkinsonian Speech

T.S. Tong, M.W. Ng (Pokfulam, Hong Kong)

Meeting: 2018 International Congress

Abstract Number: 400

Keywords: Dysarthria, Parkinsonism, Rehabilitation

Session Information

Date: Saturday, October 6, 2018

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: The current study compared the effects of expiratory muscle strength training (EMST) and EMST plus voice therapy (VT) on speech loudness and intelligibility of speech in Parkinson’s disease.

Background: Hypophonia, characterized by a reduced speech loudness, is a major speech disturbance associated with PD. Expiratory muscle strength training (EMST) was found effective in improving respiratory and phonatory functions in PD by an intensive blowing exercise using a resistive pressure-threshold instrument. To supplement the strength training effect of EMST, skill training such as breath-speech coordination and loudness projection have been proven useful in other populations such as elderly, teachers and salesperson.

Methods: Twenty patients with idiopathic PD (in mild or moderate stage) were recruited and randomly assigned to EMST group and EMST-VT group. Both groups received a 4-week EMST training and EMST-VT group received an additional voice therapy. Outcome measures included maximum expiratory pressure (MEP), maximum phonation time (MPT), speech loudness during vowel prolongation (SL), speech loudness during passage reading (SL-pass), intelligibility rating score (IRS) and Voice Handicap Index (VHI).

Results: No pre-treatment group differences were observed in all measures. Significant treatment effects were noted in all measures (except VHI for EMST-VT group) in pre-post treatment comparison of both groups. Remarkably, a greater improvement in SL (p < 0.001) and SL-Pass (p < 0.05) was found in EMST-VT group while other measures showed similar improvement.

Conclusions: These findings demonstrated the effect of EMST on speech loudness in PD could be enhanced if it is combined with an intensive voice therapy. The difference in nature of strength training and skill training can explain the results.

References: Troche, M. S., Okun, M. S., Rosenbek, J. C., Musson, N., Fernandez, H. H., Rodriguez, R., … Sapienza, C. (2010). Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial. Neurology, 75(21), 1912-1919. Wingate, J. M., Brown, W. S., Shrivastav, R., Davenport, P., & Sapienza, C. M. (2007). Treatment Outcomes for Professional Voice Users. Journal of Voice, 21(4), 433-449.

To cite this abstract in AMA style:

T.S. Tong, M.W. Ng. Effects of Expiratory Muscle Strength Training and Voice Therapy on Parkinsonian Speech [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/effects-of-expiratory-muscle-strength-training-and-voice-therapy-on-parkinsonian-speech/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effects-of-expiratory-muscle-strength-training-and-voice-therapy-on-parkinsonian-speech/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley